Dipeptidylpeptidase-4 (DPP-4) inhibitors

Go to algorithm

exp date isn't null, but text field is

For use in type 2 diabetes, refer to: Achieving Control in Type 2 diabetes

ALOGLIPTIN (First Line)

Therapy notes

Formulation

Tablets 6.25mg, 12.5mg, 25mg

LINAGLIPTIN

Therapy notes

First-line DPP-4 inhibitor of choice in any degree of renal impairment.

Formulation

Tablets 5mg